Table 3

CDKN1B genotype analysis

VVVGGGOR VV vs. VG, GG
Cases (n = 96)67 (70%)24 (25%)5 (5%)1.95 (95% CI, 1.09–3.47)
 Androgen-dependent disease (n = 40)27 (68%)11 (27%)2 (5%)1.75 (95% CI, 0.81–3.76)
 Androgen-independent disease (n = 56)40 (72%)13 (23%)3 (5%)2.11 (95% CI, 1.05–4.22)
 Age ≤ median (n = 51)37 (73%)12 (23%)2 (4%)2.23 (95% CI, 1.08–4.59)
 Age > median (n = 45)30 (67%)12 (27%)3 (6%)1.68 (95% CI, 0.81–3.50)
Controls (n = 105)a57 (54%)38 (36%)10 (10%)1.0 (reference)
  • a CDKN1B genotype was not determined for one control.